StockNews.com assumed coverage on shares of Arch Biopartners (NYSE:ARCH – Free Report) in a research report report published on Tuesday morning. The brokerage issued a hold rating on the stock.
Arch Biopartners Stock Performance
ARCH opened at $134.83 on Tuesday. Arch Biopartners has a 12 month low of $116.44 and a 12 month high of $180.65.
Read More
- Five stocks we like better than Arch Biopartners
- 3 Warren Buffett Stocks to Buy Now
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- Investing in Travel Stocks Benefits
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
